NanoDSF und DLS for Protein Characterization

The development of biopharmaceutical products from the idea to the mature product is time-consuming and requires enormous resources. An essential part of the development of therapeutic antibodies, nanobodies, enzymes or other biotechnologically produced proteins is the characterization of their functionality and stability.

A targeted selection of potential candidate molecules in combination with an efficient production and formulation process, followed by fast and reliable quality control, are the key to successful product development.

At the workshop, learn about novel technologies and approaches that have the potential to shorten the time to market for your biotherapeutics and enzyme screening development project.

You can find more information on the agenda in the following flyer.

Click here to register: NMI and NanoTemper Workshop: Biomolecular Interactions and Protein Stability Characterization - NanoTemper Technologies